Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in adults aged 65 years or older: A prospective study
Christenson B., Lundbergh P., Hedlund J. et al. Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in adults aged 65 years or older: a prospective study. Lancet 2001; 357: 1008-1011.
Mortality associated with influenza and respiratory syncytial virus in the United States
Thompson W. W., Shay D. K., Weintraub E. et al. Mortality associated with influenza and respiratory syncytial virus in the United States. J. A. M. A. 2003; 289: 179-186.
Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly
Nichol K. L., Nordin J., Mullooly J., Lask R. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N. Engl. J. Med. 2003; 348: 1322-1332.
Influenza vaccination programs for elderly persons: Cost-effectiveness in a health maintenance organization
Mullooly J. P., Bennett M. D., Hornbrook M. C. et al. Influenza vaccination programs for elderly persons: cost-effectiveness in a health maintenance organization. Ann. Intern. Med. 1994; 121: 947-952.
The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community
Nichol K. L., Margolis K. L., Wuorenma J., von Sternberg T. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N. Engl. J. Med. 1994; 331: 778-784.
Influenza vaccine effectiveness in preventing hospitalizations and deaths in persons 65 years or older in Minnesota, New York, and Oregon: Data from 3 health plans
Nordin J., Mullooly J., Poblete S. et al. Influenza vaccine effectiveness in preventing hospitalizations and deaths in persons 65 years or older in Minnesota, New York, and Oregon: data from 3 health plans. Infect. Dis. 2001; 184: 665-670.